US seeks $3.3 billion for Novartis 'kickbacks'
AFP · 1 Jul 2015, 15:48
Published: 01 Jul 2015 15:48 GMT+02:00
- Biogen announces billion-franc drugs plant (30 Jun 15)
- Novartis profits and sales slip in first quarter (23 Apr 15)
- Japan orders Novartis unit to suspend activities (27 Feb 15)
The legal filing made Monday to a New York court by US officials details 126,802 prescriptions for Novartis medication Exjade, and 39,209 for Myfortic submitted by pharmacies for a total $508 million in reimbursements from government health care programs.
The complaint by US authorities alleges Basel-based Novartis coaxed pharmacy chains to convince customers to fill or refill relevant prescriptions with Exjade or Myfortic — which respectively lowers blood iron levels and combats the risk of rejection in kidney transplant patients — in exchange for rebates and other advantages.
The filing notes that Novartis maintains it offered legal rebates to pharmacies it worked with.
Convinced the arrangement unfairly cost government health programmes millions of dollars in reimbursed drug purchases, US justice officials are seeking three times the amount paid out — or up to $11,000 per prescription.